2016-03-05T00:00:00.000-05:00
Celgene Co.,0.0271957
Director Ernest Mario,-0.314735
integrated biopharmaceutical company,0.302063
price objective,0.297519
quarterly earnings results,-0.250176
RBC Capital,0.336821
recent quarter,0.361952
research analysts,-0.224584
midday trading,-0.236862
stock,0.0744146
Investment Management Company,0.517243
Edge Wealth Management,0.45926
InvestorPlace Broker Center,0.555736
Crocker Inc.,-0.0468011
Renaissance Investment Group,0.209371
research report,0.388785
biopharmaceutical company,0.383856
Director Michael D.,-0.278672
sell rating,0.350804
personal trading style,0.598412
Winslow Evans,-0.0468011
Celgene,-0.162117
average price,0.123917
shares,0.101564
consensus estimate,-0.296408
Capital Investment Services,0.343375
concise daily summary,0.449296
average target price,-0.325261
Canaccord Genuity,0.263231
Indiana Trust,0.517243
stock broker,0.245696
consensus rating,0.406148
recent Form,0.347093
new position,0.343375
quarter,-0.0114146
